How We Approach Bridging Pediatric Sickle Cell Care and the School Experience [0.03%]
我们如何弥合儿科镰状细胞病护理与学校体验之间的联系
Meaghann S Weaver,Marshetta Brazley-Rodgers,Abagail D Cohen et al.
Meaghann S Weaver et al.
Children with sickle cell disease (SCD) experience school-based barriers that affect well-being and long-term outcomes. This article reframes school as a partner and core site of care. Because SCD is chronic, variable, and often invisible, ...
Rapid Molecular Diagnostics Enables Individualized Frontline Treatment of CBFA2T3::GLIS2-Rearranged Acute Myeloid Leukemia [0.03%]
快速分子诊断可指导CBFA2T3::GLIS2重排急性髓系白血病的个体化一线治疗
Joanne C Alfred,Julie K Geyer,Alexa Rodriguez et al.
Joanne C Alfred et al.
In this paper, we discuss how Nanopore whole genome sequencing (WGS) was utilized for rapid genomic identification of CBFA2T3::GLIS2-rearranged acute myeloid leukemia (AML) for two pediatric patients. Patients with CBFA2T3::GLIS2 AML have a...
Terminal Complement Inhibition for Refractory IgA-Mediated Autoimmune Hemolytic Anemia in a Pediatric Heart Transplant Recipient [0.03%]
小儿心脏移植受者的难治性IgA介导自身免疫溶血性贫血的末端补体抑制治疗
Akhila Arcot Vadivelan,Taizo Nakano,Melanie D Everitt
Akhila Arcot Vadivelan
Development and Implementation of a Disease-Targeted Storybook as a Clinical Tool for Children With Acute Leukemia [0.03%]
一种针对疾病的故事书在急性白血病儿童中的开发和应用临床工具研究
Nutvipha Ummartyotin,Usanarat Anurathapan,Rawiwan Roongpraiwan et al.
Nutvipha Ummartyotin et al.
Background: Although significant progress has been made in childhood leukemia survival, healthcare providers, and caregivers often face challenges in explaining this disease to patients. Disease-targeted storybooks have b...
The Role of Chemotherapy in Pediatric Myoepithelial Carcinoma: A Systematic Review of the Literature [0.03%]
儿童肌上皮癌化疗作用的文献系统回顾
Marco Salvi,Maria Carmen Affinita,Giulia Fichera et al.
Marco Salvi et al.
Myoepithelial carcinoma (MEC) in pediatric patients is a rare and aggressive malignancy characterized by heterogeneous morphology and variable molecular features. The optimal role of chemotherapy remains unclear. We conducted a systematic r...
Determining Parental Factors for Clinical Trial Attrition in Pediatric Acute Lymphoblastic Leukemia [0.03%]
儿科急性淋巴细胞白血病临床试验脱落的家长因素确定
Kimberly L Stathas,Jakob Q Weiss,Kellee N Parker et al.
Kimberly L Stathas et al.
Background/objectives: Despite high enrollment rates on Children's Oncology Group (COG) protocols, attrition after initial consent is challenging, introducing bias and prolonging trial completion. While adult oncology lit...
Global Disparities in Pediatric Radiotherapy Infrastructure and Access: A Scoping Review With a Focused Analysis of Morocco [0.03%]
全球儿童放射治疗基础设施和获取的差异：一种以摩洛哥为重点分析的综述研究
Amal Ben Lachger,Redouane El Baydaoui
Amal Ben Lachger
Radiotherapy (RT) is a crucial component of childhood cancer management; however, its global availability and technological capacity remain highly heterogeneous. Despite increasing international attention to childhood cancer care, comprehen...
Natural Killer Cells in Paediatric Soft Tissue Sarcomas: A Systematic Review [0.03%]
儿童软组织肉瘤中的自然杀伤细胞：系统性综述
Raya Dean,Lara V Graham,Christina Putnam et al.
Raya Dean et al.
Paediatric soft tissue sarcomas (pSTS) are a rare and heterogeneous group of malignant tumours arising in tissues of mesenchymal origin. The role of natural killer (NK) cells in pSTS remains poorly understood, with evidence fragmented acros...
Job Satisfaction and Career Development Outlooks for Pediatric Hematology/Oncology Physician Hospitalists [0.03%]
儿科血液肿瘤内科医师医院工作者的职业满意度及发展前景展望
Zachary D Prudowsky,Jason Freedman,Liza-Marie Johnson et al.
Zachary D Prudowsky et al.
Increasing complexity of inpatient pediatric hematology/oncology (PHO) with evolving workforce infrastructure has led many institutions to develop PHO hospitalist programs. As these programs grow, so too does the need to sustain staffing mo...
Out of Reach: Understanding Resource Barriers to Gene Therapy for Pediatric Patients With Sickle Cell Disease [0.03%]
难以企及：了解基因治疗儿科镰状细胞病患者的资源障碍
Colleen A Kelly,Morgan A Paul,McKenzie Griffin et al.
Colleen A Kelly et al.
Background: Sickle cell disease (SCD) is a highly morbid condition resulting in poor quality of life and early death. Gene therapy offers opportunity for cure, but its resource‑ and time‑intensive nature may limit acces...